CS logo
small CS logo
Israelitisches Krankenhaus

Hamburg, Germany
General hospital in Hamburg
Orchideenstieg 14, 22297 Hamburg

About Israelitisches Krankenhaus


The Jewish Hospital in Hamburg is a Jewish medical institution in Hamburg, Germany. It is particularly renowned for its treatment of gastric and bowel cancer.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Israelitisches Krankenhaus


During the past decade, Israelitisches Krankenhaus conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Israelitisches Krankenhaus" #1 collaborator was "KARL STORZ GmbH & Co. KG, Tuttlingen, Germany" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Israelitisches Krankenhaus


According to Clinical.Site data, the most researched conditions in "Israelitisches Krankenhaus" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Choledocholithiasis" (1 trials), "Cholestasis" (1 trials) and "Chronic Idiopathic Constipation" (1 trials). Many other conditions were trialed in "Israelitisches Krankenhaus" in a lesser frequency.

Clinical Trials Intervention Types at Israelitisches Krankenhaus


Most popular intervention types in "Israelitisches Krankenhaus" are "Drug" (5 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Relamorelin" (3 trials), "EUS-FNB with EZ Shot 2 19G first" (1 trials), "EUS-FNB with EZ Shot 3Plus first" (1 trials) and "Elobixibat 10 mg" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Israelitisches Krankenhaus


The vast majority of trials in "Israelitisches Krankenhaus" are 7 trials for "All" genders.

Clinical Trials Status at Israelitisches Krankenhaus


Currently, there are NaN active trials in "Israelitisches Krankenhaus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Israelitisches Krankenhaus, undefined suspended trials, and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Israelitisches Krankenhaus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".